Antibody Library Technology Market Report 2022: Rising Demand for Highly Targeted Therapies Driving Growth –

Antibody Library Technology Market Report 2022: Rising Demand for Highly Targeted Therapies Driving Growth –

Antibody Library Technology Market Report 2022: Rising Demand for Highly Targeted Therapies Driving Growth –

DUBLIN–(BUSINESS WIRE)–The “Antibody Library Technology Market Analysis, by Technology, by Application, by End User, and by Region – Global Forecast to 2029” report has been added to’s offering.

The antibody library technology market size is estimated to be USD 145.71 million in 2021 and is expected to witness a CAGR of 4.76% during the forecast period 2022-2029. The rising demand for highly targeted therapies to treat a variety of serious diseases like cancer and other diseases, increased incidence of chronic disorders are factors contributing to the market growth. However, high price is expected to hinder the growth.

By Technology

Based on technology, the market is categorized into ribosome display, mammalian cell surface display, phage display, and yeast display. In 2021, the phage display and yeast display accounted for the highest revenue share due to the fact that yeast surface display is an effective technique for isolating and engineering antibodies to increase their affinity and stability and that phage display is widely used because it is a versatile in vitro selection technology that is used to find high affinity.

By Application

On the basis of application, the market is categorized into drug discovery & development and research application. In the global market, the drug discovery & development segment accounted for the largest revenue share in 2021 owing to the fact that it is used in several drug discovery and development trials for the treatment of many rare diseases, including cancer and HIV.

By End User

Based on end user, the market is segmented into academic & research institutes, biopharmaceutical companies, and contract research organization. In 2021, the biopharmaceutical companies segment accounted for the largest revenue share owing to fact that they employ antibody library technology for a variety of therapeutic treatments.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including technology, application, and end user from 2021 to 2029.

Segmentation: Antibody Library Technology Market Report 2021-2029 Technology (Revenue, USD Million)

  • Ribosome Display
  • Mammalian Cell Surface Display
  • Phage Display
  • Yeast Display

Application (Revenue, USD Million)

  • Drug Discovery & Development
  • Research Application

End user (Revenue, USD Million)

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Organization

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada


  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Antibody Library Technology

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Antibody Library Technology Market

7. Market Analysis by Technology

8. Market Analysis by Application

9. Market Analysis by End User

10. Regional Market Analysis

11. North America Antibody Library Technology Market

12. Europe Antibody Library Technology Market

13. Asia Pacific Antibody Library Technology Market

14. Latin America Antibody Library Technology Market

15. MEA Antibody Library Technology Market

16. Competitor Analysis

17. Company Profiles

18. Conclusion & Recommendations

Companies Mentioned

  • Abcam plc. (UK)
  • Cell Signaling Technology (US)
  • Analytik Jena AG (Germany)
  • Becton
  • Dickinson and Company (US)
  • Bio-Rad Laboratories (US)
  • F. Hoffmann-La Roche (Switzerland)
  • Agilent Technologies (US)
  • PerkinElmer (US)
  • GenScript (China)
  • BioLegend (US)
  • Illumia Inc. (US)
  • ImmonoPresice Antibodies (Canada)
  • Thermo Fisher Scientific Inc. (US)
  • Fujirebio (Sweden)
  • Omega BioTek (US)
  • Merck KGaA (Germany)
  • Danaher Corporation (US)
  • Dovetail Genomics (US)
  • Lonza (Switzerland)
  • Atlas Antibodies (Sweden)

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900